• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank

    5/13/24 9:15:08 AM ET
    $BAC
    $BIIB
    $CVX
    $FIHL
    Major Banks
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $BAC alert in real time by email

    On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Micron (NASDAQ:MU), adding that he likes the company and its CEO Sanjay Mehrotra.

    On May 6, Baird analyst Tristan Gerra upgraded Micron from Neutral to Outperform and raised the price target from $115 to $150.

    Bank of America Corporation (NASDAQ:BAC) is a buy, Cramer said.

    Earlier this month, Bank of America recommended shareholders reject “mini-tender” offer by Tutanota LLC.

    When asked about JFrog Ltd. (NASDAQ:FROG), he said, “I would be a seller of almost all the enterprise software companies here.”

    On May 9, JFrog posted stronger-than-expected results for its first quarter. The company also said it sees FY24 adjusted earnings of 59 cents to 61 cents per share, on revenue of $425.5 million to $429.5 million.

    The “Mad Money” host said he is not impressed with what Biogen (NASDAQ:BIIB) is doing.

    On April 24, Biogen reported first-quarter adjusted EPS of $3.67, up 8%, beating the consensus of $3.44.

    Cramer said Fidelis Insurance Holdings Limited (NYSE:FIHL) is “not a favorite.”

    On May 9, Fidelis Insurance posted better-than-expected earnings for its first quarter.

    Chevron Corporation (NYSE:CVX) is a buy, he said.

    On May 10, Truist Securities analyst Neal Dingmann maintained Chevron with a Hold and raised the price target from $156 to $166.

    Price Action:

    • Biogen shares fell 0.6% to settle at $221.50 on Friday.
    • Micron shares fell 4.8% to close at $6.09.
    • Bank of America shares gained 0.4% to settle at $38.45.
    • Fidelis Insurance shares fell 4.3% to close at $18.48 on Friday.
    • JFrog shares dipped 18.7% to settle at $33.01 on Friday.
    • Chevron shares gained 0.2% to close at $165.82.

    Read Next: Top 3 Industrials Stocks That May Collapse This Month

    Image: Shutterstock

    Get the next $BAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAC
    $BIIB
    $CVX
    $FIHL

    CompanyDatePrice TargetRatingAnalyst
    Biogen Inc.
    $BIIB
    2/20/2026$185.00Equal Weight
    Barclays
    Chevron Corporation
    $CVX
    2/17/2026$205.00Hold → Buy
    Melius
    Micron Technology Inc.
    $MU
    2/17/2026$380.00 → $450.00Buy
    Needham
    Biogen Inc.
    $BIIB
    2/9/2026$194.00 → $228.00Buy
    H.C. Wainwright
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$180.00Buy → Hold
    HSBC Securities
    Micron Technology Inc.
    $MU
    1/23/2026$350.00 → $500.00Buy
    HSBC Securities
    Micron Technology Inc.
    $MU
    1/22/2026Outperform
    William Blair
    More analyst ratings

    $BAC
    $BIIB
    $CVX
    $FIHL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    JFrog to Present at Upcoming Investor Conferences

    JFrog Ltd. ("JFrog") (NASDAQ:FROG), the Liquid Software Company and creators of the JFrog Software Supply Chain Platform, today announced that it will present at the following investor conferences during the first quarter of 2026: Morgan Stanley Technology, Media & Telecom Conference in San Francisco, California, Monday, March 2nd, at 11:30 a.m. Pacific Daylight Time Raymond James Institutional Investor Conference in Orlando, Florida, Wednesday, March 4th, at 10:40 a.m. Pacific Daylight Time Cantor Global Technology & Industrial Growth Conference in New York, New York, Wednesday, March 11th, at 7:00 a.m. Pacific Daylight Time The live webcasts and replays will be available on JF

    2/23/26 4:05:00 PM ET
    $FROG
    Computer Software: Prepackaged Software
    Technology

    24 Merrill Advisors Recognized on Financial Planning's Top 40 Brokers Under 40 List

    Merrill Leads List With Most Advisors Named for Seventh Consecutive YearNEW YORK, Feb. 20, 2026 /PRNewswire/ -- Financial Planning recognized 24 Merrill Wealth Management and Merrill Private Wealth Advisors on its annual Top 40 Brokers Under 40. For the seventh consecutive year, Merrill has had more advisors on the list than any other firm underscoring the strength of Merrill's talent and the company's commitment to advisor development at every stage of their careers. (Rankings published February 10, 2026, based on data as of September 30, 2025.) "We're proud of these advisors a

    2/20/26 9:00:00 AM ET
    $BAC
    Major Banks
    Finance

    Fidelis Insurance Group Expands Capital Management Initiatives

    Increases common share repurchase authorization, bringing the total current authorization to $400 million Announces quarterly dividend of $0.15 per common share payable March 27, 2026 Fidelis Insurance Holdings Limited (NYSE:FIHL) ("Fidelis Insurance Group" or "the Company"), a strategic capital allocator and risk selector in specialty insurance and reinsurance, announced today an expansion of its capital management initiatives. The Company's Board of Directors approved an increase to the current common share repurchase authorization to $400 million and additionally approved and declared a dividend of $0.15 per common share, payable on March 27, 2026, to shareholders of record on March

    2/20/26 8:30:00 AM ET
    $FIHL
    Property-Casualty Insurers
    Finance

    $BAC
    $BIIB
    $CVX
    $FIHL
    SEC Filings

    View All

    SEC Form FWP filed by Bank of America Corporation

    FWP - BANK OF AMERICA CORP /DE/ (0000070858) (Subject)

    2/24/26 1:04:52 PM ET
    $BAC
    Major Banks
    Finance

    SEC Form FWP filed by Bank of America Corporation

    FWP - BANK OF AMERICA CORP /DE/ (0000070858) (Subject)

    2/24/26 12:04:48 PM ET
    $BAC
    Major Banks
    Finance

    SEC Form FWP filed by Bank of America Corporation

    FWP - BANK OF AMERICA CORP /DE/ (0000070858) (Subject)

    2/24/26 10:11:53 AM ET
    $BAC
    Major Banks
    Finance

    $BAC
    $BIIB
    $CVX
    $FIHL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-15) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211855, Application Classification: Labeling

    3/25/24 4:41:37 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BAC
    $BIIB
    $CVX
    $FIHL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, DM&C Walz Andrew Benjamin sold $268,950 worth of shares (1,463 units at $183.83), closing all direct ownership in the company (SEC Form 4)

    4 - CHEVRON CORP (0000093410) (Issuer)

    2/20/26 4:46:46 PM ET
    $CVX
    Integrated oil Companies
    Energy

    Controller Knowles Alana K sold $441,327 worth of shares (2,408 units at $183.28), closing all direct ownership in the company (SEC Form 4)

    4 - CHEVRON CORP (0000093410) (Issuer)

    2/20/26 4:44:53 PM ET
    $CVX
    Integrated oil Companies
    Energy

    Vice Chair, Head Ent Credit Thompson Bruce R. covered exercise/tax liability with 103,927 shares, returned $1,399,301 worth of shares to the company (26,628 units at $52.55) and converted options into 239,926 shares, increasing direct ownership by 15% to 859,151 units (SEC Form 4)

    4 - BANK OF AMERICA CORP /DE/ (0000070858) (Issuer)

    2/18/26 7:11:05 PM ET
    $BAC
    Major Banks
    Finance

    $BAC
    $BIIB
    $CVX
    $FIHL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Head of Pharm Ops and Tech Murphy Nicole bought $585 worth of shares (3 units at $195.03), increasing direct ownership by 0.02% to 19,611 units (SEC Form 4)

    4 - BIOGEN INC. (0000875045) (Issuer)

    2/17/26 8:16:40 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Bank Of America Corp /De/ bought $4,303 worth of shares (343 units at $12.55) and sold $4,202 worth of shares (343 units at $12.25) (SEC Form 4)

    4 - BANK OF AMERICA CORP /DE/ (0000070858) (Reporting)

    1/28/26 1:23:38 PM ET
    $BAC
    Major Banks
    Finance

    Director Liu Teyin M bought $7,821,723 worth of shares (23,200 units at $337.14), increasing direct ownership by 856% to 25,910 units (SEC Form 4)

    4 - MICRON TECHNOLOGY INC (0000723125) (Issuer)

    1/15/26 7:07:13 PM ET
    $MU
    Semiconductors
    Technology

    $BAC
    $BIIB
    $CVX
    $FIHL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Biogen with a new price target

    Barclays initiated coverage of Biogen with a rating of Equal Weight and set a new price target of $185.00

    2/20/26 8:23:55 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chevron upgraded by Melius with a new price target

    Melius upgraded Chevron from Hold to Buy and set a new price target of $205.00

    2/17/26 7:31:07 AM ET
    $CVX
    Integrated oil Companies
    Energy

    Needham reiterated coverage on Micron with a new price target

    Needham reiterated coverage of Micron with a rating of Buy and set a new price target of $450.00 from $380.00 previously

    2/17/26 7:06:48 AM ET
    $MU
    Semiconductors
    Technology

    $BAC
    $BIIB
    $CVX
    $FIHL
    Leadership Updates

    Live Leadership Updates

    View All

    JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

    Company Extends Executive Leadership to Lead the AI-Driven Software Supply Chain Evolution JFrog Ltd. (NASDAQ:FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog, as a seasoned CMO and go-to-market (GTM) leader with established success in driving global enterprise software growth and strategic business expansion. Coming from software development product management roots and public company GTM leadership, Ms. Murphy also holds a PhD in User Acceptance of New Technology, from the University of Wales and is a veteran of multiple boards of directors in technology and

    1/5/26 8:00:00 AM ET
    $FIVN
    $FROG
    $HPE
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Retail: Computer Software & Peripheral Equipment

    Inside the Modern Family Office: Complexity, Innovation, and a Generational Shift

    Bank of America Private Bank's Family Office Study Finds Nearly 60% of Family Offices Expect Leadership Transition Within the Next Decade NEW YORK, Nov. 12, 2025 /PRNewswire/ -- The Bank of America Family Office Study: Perspectives on the Modern Family Office reveals that the next decade will be a defining era for the world's wealthiest families. Generational transitions, economic optimism, and rapid technological advancements are reshaping how family offices manage and preserve multigenerational wealth. With 87% of family offices yet to be passed down to the next generation — and 59% expecting that transition within the next 10 years — leadership handovers are

    11/12/25 9:00:00 AM ET
    $BAC
    Major Banks
    Finance

    BofA Expands Veteran Support with $350k Grant

    250 Mentorships Celebrate 250 Years of America CHARLOTTE, N.C., Nov. 10, 2025 /PRNewswire/ -- Bank of America (BofA) today announced a $350,000 grant to American Corporate Partners (ACP), a commitment that will support 250 mentorships for veterans and military spouses today, in honor of America's 250th birthday.  ACP is a leading nonprofit dedicated to helping veterans and military spouses transition into meaningful civilian careers through one-on-one mentoring. This philanthropic investment will fund mentorship and career support over the next year, underscoring Bank of Ameri

    11/10/25 10:00:00 AM ET
    $BAC
    Major Banks
    Finance

    $BAC
    $BIIB
    $CVX
    $FIHL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Bank of America Corporation

    SC 13D/A - BANK OF AMERICA CORP /DE/ (0000070858) (Filed by)

    12/13/24 4:29:10 PM ET
    $BAC
    Major Banks
    Finance

    Amendment: SEC Form SC 13G/A filed by Fidelis Insurance Holdings Limited

    SC 13G/A - Fidelis Insurance Holdings Ltd (0001636639) (Subject)

    11/12/24 4:28:25 PM ET
    $FIHL
    Property-Casualty Insurers
    Finance

    Amendment: SEC Form SC 13G/A filed by Biogen Inc.

    SC 13G/A - BIOGEN INC. (0000875045) (Subject)

    11/12/24 1:24:28 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BAC
    $BIIB
    $CVX
    $FIHL
    Financials

    Live finance-specific insights

    View All

    24 Merrill Advisors Recognized on Financial Planning's Top 40 Brokers Under 40 List

    Merrill Leads List With Most Advisors Named for Seventh Consecutive YearNEW YORK, Feb. 20, 2026 /PRNewswire/ -- Financial Planning recognized 24 Merrill Wealth Management and Merrill Private Wealth Advisors on its annual Top 40 Brokers Under 40. For the seventh consecutive year, Merrill has had more advisors on the list than any other firm underscoring the strength of Merrill's talent and the company's commitment to advisor development at every stage of their careers. (Rankings published February 10, 2026, based on data as of September 30, 2025.) "We're proud of these advisors a

    2/20/26 9:00:00 AM ET
    $BAC
    Major Banks
    Finance

    Fidelis Insurance Group Expands Capital Management Initiatives

    Increases common share repurchase authorization, bringing the total current authorization to $400 million Announces quarterly dividend of $0.15 per common share payable March 27, 2026 Fidelis Insurance Holdings Limited (NYSE:FIHL) ("Fidelis Insurance Group" or "the Company"), a strategic capital allocator and risk selector in specialty insurance and reinsurance, announced today an expansion of its capital management initiatives. The Company's Board of Directors approved an increase to the current common share repurchase authorization to $400 million and additionally approved and declared a dividend of $0.15 per common share, payable on March 27, 2026, to shareholders of record on March

    2/20/26 8:30:00 AM ET
    $FIHL
    Property-Casualty Insurers
    Finance

    New BofA Rewards™ Program to Reach Millions More Clients with Expanded Benefits

    No Fee Loyalty Program1 Available to Any Client with a Personal Checking AccountMore Than 30 Million Clients Newly Qualify for Personalized RewardsNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Bank of America today announced plans to launch BofA Rewards, a no fee loyalty program designed to reward and recognize clients for their full relationship across their Bank of America banking and Merrill investing accounts. Starting May 27, millions of clients can enroll in the new program to unlock benefits on eligible credit cards, cash back deals, banking services, curated experiences and more. BofA Rewards members can benefit from $150 to $4,000 in annual value based on their membership tier and program

    2/18/26 1:58:00 PM ET
    $BAC
    Major Banks
    Finance